Schedule of Segment Details |
Segment details were as follows (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Mobile Solutions Segment | | Industrial Solutions Segment | | Life Sciences Segment | | Total Segment | | Corporate and Unallocated (1) | | Total Company | Year ended July 31, 2025 | | | | | | | | | | | | | Net sales | | $ | 2,291.0 | | | $ | 1,104.4 | | | $ | 295.5 | | | $ | 3,690.9 | | | $ | — | | | $ | 3,690.9 | | | | | | | | | | | | | | | Cost of sales | | 1,544.0 | | | 654.9 | | | 177.9 | | | | | | | | Other segment items (2) | | 329.4 | | | 251.8 | | | 113.2 | | | | | | | | Earnings (loss) before income taxes | | $ | 417.6 | | | $ | 197.7 | | | $ | 4.4 | | | $ | 619.7 | | | $ | (127.5) | | | $ | 492.2 | | | | | | | | | | | | | | | Equity earnings in unconsolidated affiliates | | $ | 8.1 | | | $ | 0.2 | | | $ | — | | | $ | 8.3 | | | $ | — | | | $ | 8.3 | | Assets | | $ | 1,334.8 | | | $ | 883.7 | | | $ | 458.4 | | | $ | 2,676.9 | | | $ | 300.3 | | | $ | 2,977.2 | | Equity investments in unconsolidated affiliates | | $ | 33.5 | | | $ | 0.5 | | | $ | — | | | $ | 34.0 | | | $ | — | | | $ | 34.0 | | | | | | | | | | | | | | | | | | | | | | | | | | | | Year ended July 31, 2024 | | | | | | | | | | | | | Net sales | | $ | 2,250.8 | | | $ | 1,066.5 | | | $ | 269.0 | | | $ | 3,586.3 | | | $ | — | | | $ | 3,586.3 | | | | | | | | | | | | | | | Cost of sales | | 1,524.6 | | | 624.0 | | | 156.5 | | | | | | | | Other segment items (2) | | 321.7 | | | 243.7 | | | 122.9 | | | | | | | | Earnings (loss) before income taxes | | $ | 404.5 | | | $ | 198.8 | | | $ | (10.4) | | | $ | 592.9 | | | $ | (57.6) | | | $ | 535.3 | | | | | | | | | | | | | | | Equity earnings in unconsolidated affiliates | | $ | 7.3 | | | $ | 0.1 | | | $ | — | | | $ | 7.4 | | | $ | — | | | $ | 7.4 | | Assets | | $ | 1,339.5 | | | $ | 821.7 | | | $ | 512.1 | | | $ | 2,673.3 | | | $ | 241.0 | | | $ | 2,914.3 | | Equity investments in unconsolidated affiliates | | $ | 26.8 | | | $ | 0.1 | | | $ | — | | | $ | 26.9 | | | $ | — | | | $ | 26.9 | | | | | | | | | | | | | | | | | | | | | | | | | | | | Year ended July 31, 2023 | | | | | | | | | | | | | Net sales | | $ | 2,174.8 | | | $ | 1,014.7 | | | $ | 241.3 | | | $ | 3,430.8 | | | $ | — | | | $ | 3,430.8 | | | | | | | | | | | | | | | Cost of sales | | 1,535.4 | | | 594.3 | | | 136.8 | | | | | | | | Other segment items (2) | | 309.0 | | | 234.2 | | | 94.6 | | | | | | | | Earnings (loss) before income taxes | | $ | 330.4 | | | $ | 186.2 | | | $ | 9.9 | | | $ | 526.5 | | | $ | (57.8) | | | $ | 468.7 | | | | | | | | | | | | | | | Equity earnings in unconsolidated affiliates | | $ | 3.6 | | | $ | — | | | $ | — | | | $ | 3.6 | | | $ | — | | | $ | 3.6 | | Assets | | $ | 1,243.8 | | | $ | 788.1 | | | $ | 513.8 | | | $ | 2,545.7 | | | $ | 224.8 | | | $ | 2,770.5 | | Equity investments in unconsolidated affiliates | | $ | 24.2 | | | $ | 0.2 | | | $ | — | | | $ | 24.4 | | | $ | — | | | $ | 24.4 | | | | | | | | | | | | | | |
(1) Corporate and unallocated includes interest expense and certain corporate expenses determined to be non-allocable to the segments, such as restructuring charges and portions of incentive compensation. (2) Other segment items consist primarily of selling, general and administrative expenses, research and development expense and other income (expense).
|
Schedule of Reconciliation of Net Sales by Product Group Per Segment |
Net sales by business unit were as follows (in millions): | | | | | | | | | | | | | | | | | | | | | | | Year Ended July 31, | | | 2025 | | 2024 | | 2023 | Mobile Solutions segment | | | | | | | Off-Road | | $ | 359.5 | | | $ | 380.8 | | | $ | 428.7 | | On-Road | | 110.6 | | | 139.8 | | | 145.8 | | Aftermarket | | 1,820.9 | | | 1,730.2 | | | 1,600.3 | | Total Mobile Solutions segment | | 2,291.0 | | | 2,250.8 | | | 2,174.8 | | | | | | | | | Industrial Solutions segment | | | | | | | Industrial Filtration Solutions | | 914.2 | | | 901.1 | | | 872.2 | | Aerospace and Defense | | 190.2 | | | 165.4 | | | 142.5 | | Total Industrial Solutions segment | | 1,104.4 | | | 1,066.5 | | | 1,014.7 | | | | | | | | | Life Sciences segment | | | | | | | Total Life Sciences segment | | 295.5 | | | 269.0 | | | 241.3 | | | | | | | | | Total Company | | $ | 3,690.9 | | | $ | 3,586.3 | | | $ | 3,430.8 | |
|
Schedule of Net Sales by Origination and Property, Plant and Equipment by Geographic Region |
Net sales, generally disaggregated by location where the customer’s order was received, property, plant and equipment, net and right-of-use asset by geographic region were as follows (in millions): | | | | | | | | | | | | | | | | | | | | | | | Net Sales | | Property, Plant and Equipment, Net | | Right-Of-Use Asset | Year ended July 31, 2025 | | | | | | | U.S. and Canada | | $ | 1,632.3 | | | $ | 225.7 | | | $ | 26.8 | | EMEA | | 1,027.2 | | | 195.2 | | | 16.5 | | APAC | | 635.7 | | | 76.2 | | | 11.0 | | LATAM | | 395.7 | | | 147.4 | | | 6.2 | | Total | | $ | 3,690.9 | | | $ | 644.5 | | | $ | 60.5 | | | | | | | | | | | | | | | | Year ended July 31, 2024 | | | | | | | U.S. and Canada | | $ | 1,583.1 | | | $ | 209.7 | | | $ | 23.3 | | EMEA | | 1,012.9 | | | 199.6 | | | 19.1 | | APAC | | 601.5 | | | 75.5 | | | 10.6 | | LATAM | | 388.8 | | | 160.7 | | | 6.7 | | Total | | $ | 3,586.3 | | | $ | 645.5 | | | $ | 59.7 | | | | | | | | | | | | | | | | Year ended July 31, 2023 | | | | | | | U.S. and Canada | | $ | 1,464.7 | | | $ | 219.7 | | | $ | 25.3 | | EMEA | | 1,007.8 | | | 202.4 | | | 15.5 | | APAC | | 608.8 | | | 76.5 | | | 11.6 | | LATAM | | 349.5 | | | 154.3 | | | 7.1 | | Total | | $ | 3,430.8 | | | $ | 652.9 | | | $ | 59.5 | |
|